- Home
- SGBX vs PTIX Comparison
SGBX vs PTIX Comparison
Compare SGBX & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- PTIX
- Stock Information
- Founded
- SGBX 2007
- PTIX 1994
- Country
- SGBX United States
- PTIX United States
- Employees
- SGBX N/A
- PTIX 3
- Industry
- SGBX RETAIL: Building Materials
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- PTIX Health Care
- Exchange
- SGBX Nasdaq
- PTIX Nasdaq
- Market Cap
- SGBX 2.7M
- PTIX 2.8M
- IPO Year
- SGBX 2017
- PTIX 2016
- Fundamental
- Price
- SGBX $0.60
- PTIX $3.26
- Analyst Decision
- SGBX
- PTIX
- Analyst Count
- SGBX 0
- PTIX 0
- Target Price
- SGBX N/A
- PTIX N/A
- AVG Volume (30 Days)
- SGBX 166.7K
- PTIX 168.8K
- Earning Date
- SGBX 08-13-2025
- PTIX 08-13-2025
- Dividend Yield
- SGBX N/A
- PTIX N/A
- EPS Growth
- SGBX N/A
- PTIX N/A
- EPS
- SGBX N/A
- PTIX N/A
- Revenue
- SGBX $4,574,857.00
- PTIX N/A
- Revenue This Year
- SGBX $1,628.82
- PTIX N/A
- Revenue Next Year
- SGBX N/A
- PTIX N/A
- P/E Ratio
- SGBX N/A
- PTIX N/A
- Revenue Growth
- SGBX N/A
- PTIX N/A
- 52 Week Low
- SGBX $0.30
- PTIX $2.35
- 52 Week High
- SGBX $2.57
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- SGBX 43.31
- PTIX 43.21
- Support Level
- SGBX $0.59
- PTIX $3.18
- Resistance Level
- SGBX $0.64
- PTIX $3.39
- Average True Range (ATR)
- SGBX 0.04
- PTIX 0.23
- MACD
- SGBX 0.00
- PTIX -0.02
- Stochastic Oscillator
- SGBX 20.81
- PTIX 14.29
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.